Why these 4 ASX shares are in trading halts

The market may have taken a little tumble today, but not all shares will be following it lower.

Four shares that are currently in trading halts are listed below. Here’s why they are out of action at the moment:

Atlas Iron Limited (ASX: AGO)

This iron ore producer’s shares went into a trading halt yesterday pending an announcement by the company in relation to media speculation. The speculation is that Mineral Resources Limited (ASX: MIN), also in a trading halt, is interested in acquiring Atlas Iron after missing out on AWE Limited (ASX: AWE). Given the low quality of Atlas Iron’s produce and the preference for high grade ore, I’m a little surprised that Mineral Resources would be interested in it. Management may be expecting a change in market dynamics in the near future.

Lucapa Diamond Co Ltd (ASX: LOM)

This diamond producer requested a trading halt pending the announcement of a significant funding package to advance its diamond projects, including an extensive follow-up drilling and exploration program at its Brooking diamond discovery site. According to The Australian, Lucapa aims to raise $15 million in order to crank up exploration activities to see if Brooking can emerge as Australia’s next great diamond discovery. This is great timing for the company given that rival Argyle Diamonds, Australia’s biggest diamond mine and the source of rare and prized fancy pink gems, is nearing the end of its mine life. That mine currently supplies an estimated 10% of the world’s diamonds.

Wattle Health Australia Ltd (ASX: WHA)

This fledgling infant formula and baby food company’s shares have been suspended from quotation at the request of the company pending the release of an announcement regarding the finalisation of a joint venture with Organic Dairy Farmers of Australia and a potential capital raise. As this is expected to take some time to sort out, the company has skipped the trading halt and gone straight into a suspension which affords it more time. Wattle Health’s shares are expected to be offline until April 20. This morning Wattle Health reported gross sales for the March 2018 quarter of $804,379. Its market capitalisation stands at a lofty $330 million at the time of writing.

Whilst these shares are halted I would suggest investors consider buying these top growth shares instead.

3 Explosive Growth Shares To Buy In April

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.